Fineline Cube

Follow:
14486 Articles
Sanofi to Acquire Vicebio Ltd for Up to USD 1.6 Billion, Advancing Next-Gen Vaccine Development
CompanyDeals

Sanofi to Acquire Vicebio Ltd for Up to USD 1.6 Billion, Advancing Next-Gen Vaccine Development

AstraZeneca to Invest $50 Billion in US Manufacturing and R&D Expansion by 2030
Company

AstraZeneca to Invest $50 Billion in US Manufacturing and R&D Expansion by 2030

Genentech's Astegolimab Shows Promising Results in Phase IIb COPD Trial
CompanyDrug

Genentech’s Astegolimab Shows Promising Results in Phase IIb COPD Trial

AstraZeneca's FLAURA2 Study Confirms Osimertinib Combo's Survival Benefit in NSCLC
CompanyDrug

AstraZeneca’s FLAURA2 Study Confirms Osimertinib Combo’s Survival Benefit in NSCLC

Joincare's LZM012 Meets Phase III Endpoint for Psoriasis Treatment
CompanyDrug

Livzon Pharma’s LZM012 Meets Phase III Endpoint for Psoriasis Treatment

Simcere Zaiming Receives FDA Clearance for Phase I Trial of FGFR2b-Targeting ADC SIM0686
CompanyDrug

Simcere Zaiming Receives FDA Clearance for Phase I Trial of FGFR2b-Targeting ADC SIM0686

Abbott Reports Q2 2025 Sales of USD 11.14 Billion, Led by Medical Devices Growth
Company

Abbott Reports Q2 2025 Sales of USD 11.14 Billion, Led by Medical Devices Growth

DualityBio's Next-Generation HER3 ADC DB-1310 Granted FDA Fast Track Designation
CompanyDrug

DualityBio’s Next-Generation HER3 ADC DB-1310 Granted FDA Fast Track Designation

Shanghai Pharma and Cutia Therapeutic Collaborate on Codon Biopharma's Innovative Drug Distribution
CompanyDeals

Shanghai Pharma and Cutia Therapeutic Collaborate on Codon Biopharma’s Innovative Drug Distribution

Bio-Thera's BAT4406F Gets NMPA Nod for MCD and FSGS Clinical Trials
CompanyDrug

Bio-Thera’s BAT4406F Gets NMPA Nod for MCD and FSGS Clinical Trials

Huadong Medicine Receives NMPA Approval for HDM2012 Clinical Trials in Advanced Solid Tumors
CompanyDrug

Huadong Medicine Receives NMPA Approval for HDM2012 Clinical Trials in Advanced Solid Tumors

Optoseeker Biotech and BioMap Collaborate to Accelerate Antibody Therapeutics Development
CompanyDeals

Optoseeker Biotech and BioMap Collaborate to Accelerate Antibody Therapeutics Development